https://www.peptidebasics.com/retatrutide-phase-3-triumph-1-resultsPeptide Basicsen2026-10-03Retatrutide Phase 3 Results: Weight Loss, Knee Pain, and Sleep Apneahttps://www.peptidebasics.com/fda-generic-peptide-guidance-2026Peptide Basicsen2026-10-03FDA Updates the Path for Generic Peptide Drugshttps://www.peptidebasics.com/peter-attia-403-peptides-evidencePeptide Basicsen2026-10-03Peter Attia on Peptides: His Framework, the Evidence, and the Open Questionshttps://www.peptidebasics.com/weekly-oral-peptide-gzc8072-trialPeptide Basicsen2026-10-03A Once-Weekly Oral Peptide Enters Human Testinghttps://www.peptidebasics.com/redasemtide-regenerative-peptide-trials-2026Peptide Basicsen2026-10-03Redasemtide: What Two Trials Reveal About Regenerative Peptide Researchhttps://www.peptidebasics.com/fda-nuscience-peptide-warning-letter-2026Peptide Basicsen2026-10-03What FDA's Latest Peptide Warning Letter Actually Sayshttps://www.peptidebasics.com/huberman-a16z-peptides-consumer-healthPeptide Basicsen2026-10-03Andrew Huberman on Peptides and the Future of Consumer Health